The most significant risk factor is concurrent use of insulin or insulin secretagogues, including sulfonylureas (such as glimepiride, glyburide, or glipizide) and meglitinides
It does not constitute legal, financial, medical, or professional advice
Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas
During your visit, youll receive a personalized assessment to choose the right injection based on your specific needs
Visual inspection should confirm that packaging remains intact without evidence of moisture infiltration, physical damage, or temperature exposure beyond acceptable limits
Novo Nordisk, the company that makes both Ozempic and Wegovy, said it stands by the safety of its products, which includes the possible side effects listed on their labels